It is now clear that marijuana has a medicinal value, with some researchers constantly using what little resources they have to demonstrate the point. The results from such studies are amazing, showing a remarkable efficacy of the plant.
But despite these encouraging findings, the plant still remains illegal in a country where, if it is legalized, could have a significant impact on the rest of the world.
By United States federal law, marijuana is illegal irrespective of the reason for its use. The government agency responsible for the regulation of drugs in the country, the Drug Enforcement Administration (DEA), on August 11, 2016, turned down two petitions to lessen federal restrictions on marijuana. One was from the governors of Rhode Island and Washington, and the other from a resident of New Mexico, requesting that marijuana be removed from Schedule I of the Controlled Substance Act (CSA). The removal from schedule I would have ensured that official scientific research is carried out on the plant, across the United States. Yet, the DEA ruled that marijuana lacks accepted medical use and has high potential for abuse.
This arrogant DEA behavior angered Washington state officials, who responded that the state will back scientific research on marijuana, despite the federal ban. According to the Washington Post, in this confusion and disagreement between the federal agency and the various states wanting to legalize marijuana, Congress could have stepped in to resolve the conflict by amending the federal CSA, but it has declined to do so.
The latest marijuana benefits just discovered are that it can treat bone fractures and also help in organ transplants. A study conducted by Tel Aviv University and Hebrew University, in Israel, has found that the non-psychotropic component of marijuana, the cannabinoids (CBD), helps heal bone fractures.
According to the researchers, they administered CBD to rats with mid-femoral fractures and found that it markedly enhanced the healing process of the femur after just eight weeks. The researchers said they had even found in earlier studies that the human body cannabinoid receptors stimulate bone formation and inhibit bone loss. Therefore, they used the CBD as a natural progression to test how this can be utilized to promote bone healing.
Lead researcher, Dr Gabet was quoted as saying: “The clinical potential of cannabinoid-related compounds is simply undeniable at this point. While there is still a lot of work to be done to develop appropriate therapies, it is clear that it is possible to detach a clinical therapy objective from the psychoactivity of cannabis. CBD, the principal agent in our study, is primarily anti-inflammatory and has no psychoactivity.”
End of quote.
Check out the extraordinary new, life-changing technology at www.magravsplasmaproducts.com